Return to program book search
Session Information
FOC U072
-
Evidence-Based Management of the Iatrogenically Immunocompromised Patient
Subject:
Date:
Tuesday, March 05
CME Credits:
1.50
Location:
Room C225/226
Time:
7:15 AM - 8:45 AM
Director:
Peggy Wu, MD, FAAD
Learning Objectives:
Following this course, the attendee should be able to:
- Identify at-risk immunosuppressed, dermatology patients
- Examine the evidence of recommendations for screening, vaccination, and opportunistic infection prophylaxis
- Manage immunosuppressed patients with vaccination, screening, and prophylaxis strategies
Description:
More than ever, we are causing iatrogenic immunosuppression in our dermatology patients through the use of corticosteroids, mycophenolate mofetil, methotrexate, azathioprine, cyclosporine, and biologics (e.g. tumor necrosis factor antagonists, IL-12/23 inhibitors, anti B-cell therapies) and in the treatment of chronic diseases. The session reviews and analyzes the literature on disease screening, vaccinations, prophylaxis for opportunistic infections in the context of these medications, and provides recommendations for the optimal management of these patients.